A GLP-1 receptor agonist
Semaglutide acts on pathways involved in appetite and blood sugar regulation. Branded forms have different FDA-approved uses. A provider determines whether any medication is appropriate for you.
KERNX Learning Center
Back to homeWhat are Semaglutide & Tirzepatide?
Two prescription medications commonly discussed in modern weight management care, explained without the noise.
Start with the basics
A dual GIP and GLP-1 receptor agonist
Tirzepatide acts on two hormone pathways involved in appetite and metabolic regulation. Eligibility, dosing, and monitoring require an individualized clinical review.
Compounded medications are not FDA-approved products. They may be prescribed only when a licensed provider determines they are appropriate and legally available. Individual results vary.
What treatment usually involves
1. Clinical review
Your medical history, current medications, goals, and potential risk factors are reviewed by a licensed provider.
2. Personalized decision
Your provider, not an online quiz, determines whether medication is appropriate and which option may fit your needs.
3. Gradual dosing
When prescribed, treatment commonly begins at a lower dose and may be adjusted based on tolerance and clinical response.
4. Ongoing support
Nutrition, movement, sleep, and regular follow up remain important parts of a sustainable care plan.
Possible side effects
Commonly discussed
- Nausea or stomach discomfort
- Constipation or diarrhea
- Reduced appetite
- Vomiting or indigestion
When to contact your provider
Seek medical guidance for severe or persistent symptoms, signs of dehydration, intense abdominal pain, allergic reactions, or any symptom that concerns you. Your provider will review important warnings and contraindications before prescribing.
Ready for a physician led plan?
Complete the assessment. A licensed provider reviews your health history and determines whether treatment is appropriate.
Get Started →